TARGETING MCL-1 WITH UNIQUE PEPTIDE INHIBITORS DELIVERED INTRACELLULARLY USING A NOVEL NANOPARTICLE FORMULATION

$534,730FY2016Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators